ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Nov 2025
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
December 2025
Nuclear Technology
Fusion Science and Technology
November 2025
Latest News
X-energy raises $700M in latest funding round
Advanced reactor developer X-energy has announced that it has closed an oversubscribed Series D financing round of approximately $700 million. The funding proceeds are expected to be used to help continue the expansion of its supply chain and the commercial pipeline for its Xe-100 advanced small modular reactor and TRISO-X fuel, according the company.
Sakae Kinase, Shinpei Matsuhashi, Kimiaki Saito
Nuclear Technology | Volume 168 | Number 1 | October 2009 | Pages 154-157
Dose/Dose Rate | Special Issue on the 11th International Conference on Radiation Shielding and the 15th Topical Meeting of the Radiation Protection and Shielding Division (Part 1) / Radiation Protection | doi.org/10.13182/NT09-A9117
Articles are hosted by Taylor and Francis Online.
Knowledge of interspecies scaling of organ doses from experimental animals such as mice to humans is important in the preclinical evaluation of new radiopharmaceuticals. Interspecies scaling factors should be reliably determined since the dose-response relationships in mice would be translated to those in humans. To obtain reliable interspecies scaling factors of organ doses from mice to humans, absorbed fractions (AFs) are needed for sophisticated models on both mice and humans. In the present study, self-AFs for photons and electrons in the spleen, kidneys, and liver of both a mouse and humans were evaluated using Monte Carlo simulations. For the mouse and human models, voxel phantoms based on computed tomography were used. The sources were assumed to be monoenergetic in the energy range 10 keV to 4 MeV and to be uniformly distributed in the spleen, kidneys, and liver. Interspecies scaling factors were determined using the results of the self-AFs for the voxel mouse and voxel human. Consequently, interspecies scaling factors were found to be dependent upon energy emitted in the source organ. It was found that the scaling factor for the photon self-AF, which is corrected by the cube root of the organ mass, shows a similar trend as a function of energy with the scaling factor for the electron self-AF.